Published in Am J Cardiol on July 15, 2003
Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol (2011) 1.70
Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis. J Nucl Cardiol (2011) 1.47
Coronary angiography is a better predictor of mortality than noninvasive testing in patients evaluated for renal transplantation. Catheter Cardiovasc Interv (2010) 1.41
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26
Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol (2013) 1.23
Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 1.16
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90
Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) (2013) 0.86
Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol (2008) 0.84
Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82
How do We Manage Coronary Artery Disease in Patients with CKD and ESRD? Electrolyte Blood Press (2014) 0.78
Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS One (2015) 0.78
Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation. Curr Cardiol Rev (2009) 0.77
Current practice and recommendation for presurgical cardiac evaluation in patients undergoing noncardiac surgeries. World J Nucl Med (2014) 0.75
Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia (2016) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care (2004) 4.17
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging (2008) 2.42
Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol (2004) 2.36
Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA (2013) 2.34
Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol (2005) 2.27
Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology (2002) 2.26
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol (2005) 2.06
Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging. J Nucl Cardiol (2014) 1.99
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging (2009) 1.92
Usefulness of three posterior chest leads for the detection of posterior wall acute myocardial infarction. Am J Cardiol (2008) 1.77
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation (2010) 1.73
Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol (2006) 1.66
A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images. JACC Cardiovasc Imaging (2009) 1.63
Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics. J Dev Behav Pediatr (2010) 1.63
Treatment of ostial lesions using the Szabo technique: a case series. Catheter Cardiovasc Interv (2008) 1.60
The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res (2005) 1.60
The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol (2009) 1.58
Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.54
Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. JACC Cardiovasc Imaging (2012) 1.53
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%. J Am Coll Cardiol (2010) 1.50
Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care (2007) 1.46
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol (2014) 1.45
Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc Interv (2008) 1.43
The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol (2014) 1.43
Adenosine-induced ST segment depression with normal perfusion. Cardiol J (2009) 1.43
Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis (2011) 1.39
Three-dimensional balloon catheter sizing identifies significant underdeployed stents using conventional methods in renal artery interventions. J Invasive Cardiol (2008) 1.39
Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
Regadenoson: a new myocardial stress agent. J Am Coll Cardiol (2009) 1.35
Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun (2008) 1.33
Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol (2007) 1.33
Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res (2009) 1.33
Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging. J Nucl Cardiol (2004) 1.31
Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging. J Am Coll Cardiol (2006) 1.29
DUF1220-domain copy number implicated in human brain-size pathology and evolution. Am J Hum Genet (2012) 1.28
Origin of all three major coronary arteries from the right sinus of Valsalva: clinical, angiographic, and magnetic resonance imaging findings and incidence in a select referral population. Catheter Cardiovasc Interv (2007) 1.25
Maternal obesity and markers of inflammation in pregnancy. Cytokine (2009) 1.25
Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA (2003) 1.24
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial. J Am Coll Cardiol (2010) 1.22
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol (2003) 1.20
Prevalence and predictors of mechanical dyssynchrony as defined by phase analysis in patients with left ventricular dysfunction undergoing gated SPECT myocardial perfusion imaging. J Nucl Cardiol (2010) 1.14
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes. Clin J Am Soc Nephrol (2013) 1.14
Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain (2013) 1.13
Racial disparities in renal allograft survival: a public health issue? J Am Coll Surg (2007) 1.13
SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2010) 1.11
Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators. J Nucl Cardiol (2010) 1.09
Implications of left bundle branch block in patient treatment. Am J Cardiol (2012) 1.08
Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary. J Nucl Cardiol (2014) 1.08
Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J Nucl Cardiol (2008) 1.08
A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol (2011) 1.08
Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol (2012) 1.07
Takotsubo cardiomyopathy: state-of-the-art review. J Nucl Cardiol (2009) 1.06
Impact of ischemia on left ventricular dyssynchrony by phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol (2010) 1.05
Inhibition of c-Jun N-terminal kinase pathway improves cell viability in response to oxidant injury. Am J Respir Cell Mol Biol (2003) 1.04
Future applications of antioxidants in premature infants. Curr Opin Pediatr (2011) 1.03
Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol (2004) 1.01
Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol (2012) 0.99
Mitochondrial localization of catalase provides optimal protection from H2O2-induced cell death in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 0.96
Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circ Cardiovasc Imaging (2008) 0.95
SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol (2011) 0.95
Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol (2004) 0.95
Spontaneous coronary artery dissection, aneurysms, and pseudoaneurysms: a review. Echocardiography (2004) 0.94
The effects of medications on myocardial perfusion. J Am Coll Cardiol (2008) 0.94
The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease. Am Heart J (2011) 0.94
Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients. Am J Kidney Dis (2013) 0.93
Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail (2011) 0.93
Maternal obesity and neonatal Apgar scores. J Matern Fetal Neonatal Med (2010) 0.93
Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens (2003) 0.92
QT prolongation is an independent predictor of mortality in end-stage renal disease. Clin Cardiol (2010) 0.92
Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. J Nucl Cardiol (2008) 0.92
Takotsubo cardiomyopathy induced by treadmill exercise testing: an insight into the pathophysiology of transient left ventricular apical (or midventricular) ballooning in the absence of obstructive coronary artery disease. J Am Coll Cardiol (2007) 0.91
Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol (2007) 0.90
Meeting the demand for pediatric clinical trials. Sci Transl Med (2014) 0.90
Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol (2009) 0.89
Effects of transgene expression of superoxide dismutase and glutathione peroxidase on pulmonary epithelial cell growth in hyperoxia. Am J Physiol Lung Cell Mol Physiol (2004) 0.89
Percutaneous balloon pericardiotomy for the treatment of infected pericardial effusion with tamponade. J Invasive Cardiol (2006) 0.89
Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease. J Nucl Cardiol (2010) 0.89